Current Releases
Archived Releases
Media Coverage

Return to Press Releases View Archived

April 24 2007

NUCRYST Pharmaceuticals
Webcast of Conference Call to Discuss
 2007 first quarter results

Tuesday May 1, 2007
4:30 p.m. EDT

NUCRYST Pharmaceuticals Corp. will hold a webcast at 4:30 p.m. EDT on Tuesday May 1, 2007 regarding the company’s 2007 first quarter results.

In addition to standard disclosure over wire services, a news release and financial statements will be posted on the NUCRYST website. To listen to the call live on the Internet, please go to

Scott H. Gillis, President & CEO and Eliot M. Lurier, Vice President, Finance and Administration and Chief Financial Officer will participate on the call.

A complete company update will be provided on Thursday May 3, 2007 at 10:00 a.m. EDT at NUCRYST’s Annual General Meeting, which will also be webcast at

An audio file of the call will be archived and posted on the NUCRYST website.

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat™ trade mark: Acticoat™ products incorporate NUCRYST’s SILCRYST™ coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The company has developed its proprietary nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.


For more information, please contact:
Gillian McArdle
(416) 504-8464

SILCRYST™ is a trademark of NUCRYST Pharmaceuticals Corp.
Acticoat™ is a trademark of Smith & Nephew plc

Return to Press Releases View Archived

  • Stock Quote
  • Leadership
  • Join Email Club